HemoShear Therapeutics

HemoShear Therapeutics
HemoShear Therapeutics
Company Information
Company Description

HemoShear Therapeutics is a clinical stage company developing new treatments for patients with rare metabolic disorders and partnering with biopharma companies to accelerate their drug discovery and development programs in liver diseases, gout and metabolic disorders.

Industries
Biotechnology, Health Care, Medical

Please note, it is important to assess the company’s business activities against Section 1202(e)(3) which specifies certain industries that are not considered a “qualified trade or business.”

Entity Type

Per Section 1202, entities need to be a C Corporation or equivalent in order to issue QSBS.  Refer here for further details.

Incorporation State
Virginia
Qualified Small Business Stock (QSBS) Details

Exemption Level

Any individual owning stock purchased or received directly from the company could potentially be eligible for the QSBS capital gains tax exclusion or the Section 1045 gain rollover if the QSBS standards as per IRC Section 1202 were met at the time of issuance.

In order to assess whether stock issued previously may qualify, the Company would also have to have not taken actions that invalidate QSBS status such as a certain level of redemptions, and would have to satisfy the active business requirement.

Do you hold stock in this company?

Validate QSBS Eligibility
Series A Details
Series A Date
Series A Raised
$40,000,000.00
Series A Lead Investors
Suvretta Capital Management

This article does not constitute legal or tax advice. Please consult with your legal or tax advisor with respect to your particular circumstance.